← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Digital Proteomics Llc
San Diego, CA
$3,941,241
Total funding
11
Grants
Funding over time
peak $1.5M · FY2012–21$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,941,241 · 11
By mechanism
R44$2,315,047 · 5
R43$1,085,586 · 5
N43$540,608 · 1
Investigators at Digital Proteomics Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Alicanto: Proteogenomic discovery of single chain antibodies in llama$604,571
R44 · FY2020 · AI
COMPREHENSIVE REAGENTS FOR IMMUNOPHENOTYPING RABBIT CELL-MEDIATED IMMUNITY.$540,608
N43 · FY2020 · AI
An integrated transcriptomic and proteomic approach to antibody sequencing and repertoire characterization$388,404
R44 · FY2017 · GM
An integrated transcriptomic and proteomic approach to antibody sequencing and repertoire characterization$383,862
R44 · FY2018 · GM
Valens-Poly Sequencing Polyclonal Antibodies for Drug Discovery$334,446
R44 · FY2015 · GM
Valens-Poly Sequencing Polyclonal Antibodies for Drug Discovery$318,449
R44 · FY2016 · GM
Valens: A Mass Spectrometry-Based Antibody Sequencing Tool by Digital Proteomics$241,392
R43 · FY2012 · GM
Valens: A Mass Spectrometry-Based Antibody Sequencing Tool by Digital Proteomics$238,717
R43 · FY2013 · GM
Immune repertoire sequencing: error correction, analysis, and visualization on the cloud$217,313
R43 · FY2020 · GM
Quorum: natural product discovery via mass spectrometry and molecular networking$193,466
R43 · FY2018 · GM
Alicanto: Proteogenomic discovery of single chain antibodies in llama$170,108
R43 · FY2018 · AI
Quorum: glycopeptide discovery via mass spectrometry and spectral networking$146,827
R44 · FY2020 · GM
An integrated transcriptomic and proteomic approach to antibody sequencing and repertoire characterization$114,553
R44 · FY2018 · GM
Intelligent in silico antibody library design and optimization for therapeutic use$24,590
R43 · FY2021 · GM
Software for sequencing human antibody proteins from polyclonal immune responses$23,935
R44 · FY2021 · GM